Koszty Operacyjne Zmiana Data
AbbVie USD 10.52B 258M 2026-09
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Cipla INR 63.61B 1.3B 2026-09
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.44M 246K 2026-06
CSL USD 5.7B 2.82B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Novo Nordisk DKK 6.96B 30.25B 2026-06
Pfizer USD 89B 3.81B 2026-09
TherapeuticsMD USD 1.41M 50K 2024-06